Cadwalader Reps Pfizer In $3.6B King Pharma Buy
Pfizer Inc. has agreed to acquire King Pharmaceuticals Inc. for $3.6 billion in cash, expanding Pfizer's presence in the paid medication business....To view the full article, register now.
Already a subscriber? Click here to view full article